Company continues to progress both REYOBIQ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: ...

Here are three things that investors need to know about Amazon before they buy. Between 2021 and 2024, Amazon's revenue ...

Regardless of how quickly you expect it to rise in value, AMD stock can be a no-brainer buy if you're holding on for the long ...

The U.S. Department of Health and Human Services says that around 57% of Americans will need long-term care at some point ...

Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking ...

When listener Portia asked a question on the "Women & Money" podcast about her variable annuity, Suze Orman didn't hold back.

In all cases, adding budgeting to the mix involves a cost-benefit analysis where you see how much these opportunities cost and whether they are achievable in your current state. If you're a sole ...